Lymph node metastases: importance of detection and treatment strategies

Antonella Obinu, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri, Maria Cristina Bonferoni, Paolo Giunchedi

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Introduction: Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) are an important goal. Nevertheless, the targeting of the LS with traditional contrast agents and/or chemotherapeutics is difficult, due to its anatomical structure. For this reason, many studies on new lymphatic delivery systems have been carried out, both to improve lymphatic imaging and to selectively carry chemotherapeutics to LNs, reducing the exposure of healthy tissues to the cytotoxic substances. This is an overview of the present situation in the field of detection and treatment strategies of lymphatic metastases, taking into account the use of nano-drug delivery systems. Nanocarriers, thanks to their small size and other physicochemical characteristics, are suitable vectors for imaging and chemotherapy of the LS. Areas covered: The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases. Expert opinion: The nanoparticles are a promising approach for treatment and detection of lymphatic metastases. However further studies are necessary in order to evaluate their efficacy in human clinical application.

Original languageEnglish
Pages (from-to)459-467
Number of pages9
JournalExpert Opinion on Drug Delivery
Volume15
Issue number5
DOIs
Publication statusPublished - May 4 2018

Fingerprint

Lymphatic System
Lymphatic Metastasis
Lymph Nodes
Neoplasm Metastasis
Neoplasms
Individuation
Therapeutics
Lymphatic Vessels
Expert Testimony
Drug Delivery Systems
Nanoparticles
Contrast Media
Drug Therapy

Keywords

  • Cancer
  • drug delivery systems
  • lymph node metastases
  • lymphatic system
  • nanoparticles

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Lymph node metastases : importance of detection and treatment strategies. / Obinu, Antonella; Gavini, Elisabetta; Rassu, Giovanna; Maestri, Marcello; Bonferoni, Maria Cristina; Giunchedi, Paolo.

In: Expert Opinion on Drug Delivery, Vol. 15, No. 5, 04.05.2018, p. 459-467.

Research output: Contribution to journalReview article

Obinu, Antonella ; Gavini, Elisabetta ; Rassu, Giovanna ; Maestri, Marcello ; Bonferoni, Maria Cristina ; Giunchedi, Paolo. / Lymph node metastases : importance of detection and treatment strategies. In: Expert Opinion on Drug Delivery. 2018 ; Vol. 15, No. 5. pp. 459-467.
@article{b59cb595578d4a509d583dabb473f7c2,
title = "Lymph node metastases: importance of detection and treatment strategies",
abstract = "Introduction: Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) are an important goal. Nevertheless, the targeting of the LS with traditional contrast agents and/or chemotherapeutics is difficult, due to its anatomical structure. For this reason, many studies on new lymphatic delivery systems have been carried out, both to improve lymphatic imaging and to selectively carry chemotherapeutics to LNs, reducing the exposure of healthy tissues to the cytotoxic substances. This is an overview of the present situation in the field of detection and treatment strategies of lymphatic metastases, taking into account the use of nano-drug delivery systems. Nanocarriers, thanks to their small size and other physicochemical characteristics, are suitable vectors for imaging and chemotherapy of the LS. Areas covered: The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases. Expert opinion: The nanoparticles are a promising approach for treatment and detection of lymphatic metastases. However further studies are necessary in order to evaluate their efficacy in human clinical application.",
keywords = "Cancer, drug delivery systems, lymph node metastases, lymphatic system, nanoparticles",
author = "Antonella Obinu and Elisabetta Gavini and Giovanna Rassu and Marcello Maestri and Bonferoni, {Maria Cristina} and Paolo Giunchedi",
year = "2018",
month = "5",
day = "4",
doi = "10.1080/17425247.2018.1446937",
language = "English",
volume = "15",
pages = "459--467",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Lymph node metastases

T2 - importance of detection and treatment strategies

AU - Obinu, Antonella

AU - Gavini, Elisabetta

AU - Rassu, Giovanna

AU - Maestri, Marcello

AU - Bonferoni, Maria Cristina

AU - Giunchedi, Paolo

PY - 2018/5/4

Y1 - 2018/5/4

N2 - Introduction: Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) are an important goal. Nevertheless, the targeting of the LS with traditional contrast agents and/or chemotherapeutics is difficult, due to its anatomical structure. For this reason, many studies on new lymphatic delivery systems have been carried out, both to improve lymphatic imaging and to selectively carry chemotherapeutics to LNs, reducing the exposure of healthy tissues to the cytotoxic substances. This is an overview of the present situation in the field of detection and treatment strategies of lymphatic metastases, taking into account the use of nano-drug delivery systems. Nanocarriers, thanks to their small size and other physicochemical characteristics, are suitable vectors for imaging and chemotherapy of the LS. Areas covered: The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases. Expert opinion: The nanoparticles are a promising approach for treatment and detection of lymphatic metastases. However further studies are necessary in order to evaluate their efficacy in human clinical application.

AB - Introduction: Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) are an important goal. Nevertheless, the targeting of the LS with traditional contrast agents and/or chemotherapeutics is difficult, due to its anatomical structure. For this reason, many studies on new lymphatic delivery systems have been carried out, both to improve lymphatic imaging and to selectively carry chemotherapeutics to LNs, reducing the exposure of healthy tissues to the cytotoxic substances. This is an overview of the present situation in the field of detection and treatment strategies of lymphatic metastases, taking into account the use of nano-drug delivery systems. Nanocarriers, thanks to their small size and other physicochemical characteristics, are suitable vectors for imaging and chemotherapy of the LS. Areas covered: The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases. Expert opinion: The nanoparticles are a promising approach for treatment and detection of lymphatic metastases. However further studies are necessary in order to evaluate their efficacy in human clinical application.

KW - Cancer

KW - drug delivery systems

KW - lymph node metastases

KW - lymphatic system

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85045075821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045075821&partnerID=8YFLogxK

U2 - 10.1080/17425247.2018.1446937

DO - 10.1080/17425247.2018.1446937

M3 - Review article

AN - SCOPUS:85045075821

VL - 15

SP - 459

EP - 467

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 5

ER -